Download HIV Managing the Challenges

HIV – Managing the Challenges
By Dr D Spencer
References:
1. South African National Department of Health (SANDOH). National Antenatal
Sentinel HIV and Syphilis, Prevalence Survey in South Africa. 2011
2. Whiteside A. Health Economics and HIV and AIDS Research Division
(HEARD), University of KwaZulu-Natal. Keynote address delivered at the
South African AIDS Conference, June 2013.
3. Fatti G, Bock P, Grimwood A, et al. Antiretroviral therapy outcomes in rural
and urban children attending public health facilities in South Africa. 5th
Conference on HIV Pathogenesis, Treatment and Prevention, IAS 2009, Cape
Town. Poster presentation MOPEB077
4. Cleary SM, Birch S, Moshabela M, et al. Unequal access to ART: exploratory
results from rural and urban case studies of ART use. Sex Transm Infect
2012; 88:141-146
5. Kinkel HF, Adelekan AM, Marcus TS, et al. Assessment of service quality of
public antiretroviral treatment (ART) clinics in South Africa: a cross-sectional
study. BMC Health Serv Res 2012 Jul 31; 12(1): 228 [Epub ahead pf print]
PMID: 22849727.
6. Macfarlane S, Racelis M, Muli-Musiime F. Public health in developing
countries. Lancet 2000;356:841-46
7. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in
HIV care and its relevance to test-and-treat strategies for prevention of HIV
infection. Clin Infect Dis 2011; 52: 793-800
8. Rundare A, et al. Comparison 2008 and 2010 South Africa National PMTCT
Guidelines. 19th CROI, Seattle, WA. March 2012 (Abs 1003)
9. Fairall L, Bachmann MO, Lombard C, et al. Task shifting of antiretroviral
treatment from doctors to primary-care nurses in South Africa (STRETCH): a
pragmatic, parallel, cluster-randomised trial. Lancet 2012 (September 8); 380:
889-98
10. Brennan AT, Long L, Maskew M, et al. Outcomes of stable HIV-positive
patients down-referred from a doctor-managed ART clinic to a nurse-managed
primary health clinic for monitoring and treatment. AIDS 2011;25: 2027-2036
11. Long L, Brennan A, Fox MP, et al. Treatment outcomes and cost-effectiveness
of shifting management of stable ART patients to nurses in South Africa: an
observational cohort. PLOS Medicine 2011; 8: e1001055
12. Jani IL, Sitoe ER, Alfai ER, et al. Effect of point-of-care CD4 cell count tests
on retention of patients and rates of antiretroviral therapy initiation in primary
health clinics: an observational cohort study. Lancet 2011; 378: 1572-79
13. Jong E, Sanne IM, van Rie A, et al. A hospital-based tuberculosis focal point
to improve tuberculosis care provision in a very high burden setting. Public
Health Action 2013; 3(1): S1-S5. Accessed on 17.05.2013 at
http://dx.doi.org/10.5588/pha.12.0073.
14. Fatti G, Meintjes G, Shea J, et al. Improved survival and antiretroviral
treatment outcomes in adults receiving community-based adherence support:
5-year results from a multicenter cohort study in South Africa. J Acquir
Immune Defic Syndr 2012; 61(4):e50-8
15. Gardner LI, Marks G, Craw JA, et al for the Retention in Care Study Group. A
low-effort, clinic-wide intervention improves attendance for HIV primary care.
Clin Infect Dis 2012; 55(8): 1124-34
th
16. Egger M , et al. 14 CROI, Los Angeles, 2007. Abstract #62
17. Amuron B, Levin J, Birunghi J, et al. Mortality in an antiretroviral therapy
programme in Jinja, South-East Uganda: a prospective cohort study. AIDS
Research and Therapy 2011; 8: 39
18. Fregonese F, Collins IJ, Jourdain G, et al., for the HIV Prevention and
Treatment Study Group. Predictors of 5-year mortality in HIV-infected adults
starting highly active antiretroviral therapy in Thailand. J Acquir Immune Def
Syndr 2-12; 60: 91-8
19. Pandie M, van der Plas, Maartens G, et al. The role of the Infectious Diseases
Unit at Groote Schuur Hospital in addressing South Africa’s greatest burden of
disease. SAMJ 2012; 102: 528-531
20. Johnson LF, Mossong J, Dorrington RE, et al for the International
Epidemiologic Database to Evaluate AIDS Southern Africa (IeDEA-SA)
Collaboration. PLOS Medicine 2013 April; 10(4): 31001418
21. Katz IT, Essien T, Marinda ET, et al. Antiretroviral therapy refusal among
newly diagnosed HIV-infected adults. AIDS 2011; 25: 2177-218
22. Fenner L, Brinkhof MWG, Keiser O, et al, for the International Epidemiologic
Databases to Evaluate AIDS in Southern Africa (IeDEA-SA). Early mortality
and loss to follow-up in HIV-infected children starting antiretroviral therapy in
Southern Africa. J Acquir Immune Defic Syndr 2010; 54(5); 524-32
23. Crepaz N, et al. AIDS 2006;20:143-57
24. Alkire S, Chen L. Global health and moral values. The Trinity Papers. Lancet
2004; 364: 1069-74
25. Marmot M, et al. Achieving health equity: from root causes to fair outcomes.
Lancet 2007; 370: 2253-63
26. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with
immediate antiretroviral therapy as a strategy for elimination of HIV
transmission: a mathematical model. Lancet 2009; 373: 48-57
27. Cohen MS, Chen YQ, McCauley M, et al for the HPTN 052 Study Group.
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med
2011; 365: 493-505
28. Le T, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral
therapy. N Engl J Med 2013; 368: 218
29. May M, et al. Impact of late diagnosis and treatment on life expectancy in
people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011;
343: d6016. (http:dx.doi.org/10.1136/bmj.d6016)
30. World Health Organization. Antiretroviral Treatment Guidelines, 2013.
31. Quinn T, et al. (2000). N Engl J Med;342:921-9
32. Kirk G, Galai V, Astemborski J, et al. Decline in community viral load strongly
associated with declining HIV incidence among IDUs. Program of the 18th
Conference on Retroviral and Opportunistic Infections (CROI), February 27March 2, 2011, Boston, Massachusetts. Abstract 484.
33. Charlebois ED, Das M, Porco TC, et al. The effect of expanded antiretroviral
treatment strategies on the HIV epidemic among men who have sex with men
in San Francisco. Clin Infect Dis 2011; 52: 1046-49
34. Palombi L, Bernava GM, Nucita A, et al. Predicting trends in HIV-1 sexual
transmission in sub-Saharan Africa through the drug resource enhancement
against AIDS and Malnutrition model: antiretrovirals for reduction of
populations infectivity, incidence and prevalence at the district level. Clin
Infect Dis 2012; 55: 268-75
35. Carmona S, Macleod B, Cassim N, et al. A decline in community viral load in
Cape Town and Johannesburg, South Africa between 2004 and 2011.
Presentation at CROI, USA., February 2013. Abstract #1040a.
36. Estill J, Aubriere C, Egger M, et al, for IeDEA Southern Africa. Viral load
monitoring of antiretroviral therapy, cohort viral load and HIV transmission in
Southern Africa: a mathematical modeling analysis. AIDS 2012; 26: 14031413
37. Hoffman CJ, Charalambous S, Sim J, et al. Viremia, resuppression, and time
to resistance in human immunodeficiency virus (HIV) subtype C during firstline antiretroviral therapy in South Africa. Clin Infect Dis 2009; 49: 1928-35
38. Basson AE, Hoffman CJ, Charalambous S, et al. Viral re-suppression in the
presence of HIV-1 drug resistance mutations. Oral presentation. Abstract. SA
HIV Clinicians Society Conference, 25-28 November 2012, Cape Town, SA.
39. Long L, Fox M, Sanne I, et al. The high cost of second-line antiretroviral
therapy for HIV/AIDS in South Africa. AIDS 2010;24: 915-919.
40. Gupta RK, Jordan MR, Sultan BJ, et al. Global trends in antiretroviral
resistance in treatment-naïve individuals with HIV after rollout of antiretroviral
treatment in resource-limited settings: a global collaborative study and metaregression analysis. Lancet 2012; 380: 1250-58
41. Hamers RL, Sigaloff KCE, Wensing AM, et al. Patterns of HIV-1 drug
resistance after first-line antiretroviral therapy (art) failure in 6 sub-Saharan
countries: implications for second-Line ART strategies. Clin Infect Dis 2012;
54(11): 1660-9